Ingalls & Snyder LLC’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-29
| Closed | -$133K | – | 453 |
|
|
2021
Q3 | $133K | Buy |
29
+10
| +53% | +$45.9K | 0.01% | 422 |
|
|
2021
Q2 | $131K | Hold |
19
| – | – | 0.01% | 423 |
|
|
2021
Q1 | $143K | Hold |
19
| – | – | 0.01% | 405 |
|
|
2020
Q4 | $157K | Sell |
19
-1
| -5% | -$8.26K | 0.01% | 394 |
|
|
2020
Q3 | $202K | Sell |
20
-1
| -5% | -$10.1K | 0.01% | 335 |
|
|
2020
Q2 | $141K | Buy |
21
+1
| +5% | +$6.71K | 0.01% | 373 |
|
|
2020
Q1 | $89K | Hold |
20
| – | – | 0.01% | 378 |
|
|
2019
Q4 | $119K | Buy |
+20
| New | +$119K | 0.01% | 374 |
|
|
2019
Q2 | – | Sell |
-12
| Closed | -$101K | – | 417 |
|
|
2019
Q1 | $101K | Hold |
12
| – | – | ﹤0.01% | 393 |
|
|
2018
Q4 | $68K | Sell |
12
-1
| -8% | -$5.67K | ﹤0.01% | 389 |
|
|
2018
Q3 | $116K | Sell |
13
-1
| -7% | -$8.92K | ﹤0.01% | 417 |
|
|
2018
Q2 | $117K | Hold |
14
| – | – | 0.01% | 382 |
|
|
2018
Q1 | $71K | Buy |
14
+3
| +27% | +$15.2K | ﹤0.01% | 380 |
|
|
2017
Q4 | $55K | Sell |
11
-30
| -73% | -$150K | ﹤0.01% | 378 |
|
|
2017
Q3 | $446K | Sell |
41
-1
| -2% | -$10.9K | 0.02% | 249 |
|
|
2017
Q2 | $358K | Hold |
42
| – | – | 0.02% | 267 |
|
|
2017
Q1 | $398K | Hold |
42
| – | – | 0.02% | 275 |
|
|
2016
Q4 | $435K | Hold |
42
| – | – | 0.02% | 258 |
|
|
2016
Q3 | $577K | Hold |
42
| – | – | 0.03% | 230 |
|
|
2016
Q2 | $451K | Buy |
+42
| New | +$451K | 0.03% | 259 |
|